Investigation into the oncogenic potential of the androgen receptor in aromatase inhibitor resistant breast cancer

被引：0
|
作者：
Young, Leonie [1 ]
Creevey, Laura [1 ]
Ali, Azlena [1 ]
Hill, Arnold D. K. [1 ]
McIlroy, Marie [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin 2, Ireland
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-05-21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-21
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Androgen receptor signal acquired oncogenic role in aromatase inhibitor resistant model of breast cancer cell
    Fujii, R.
    Hanamura, T.
    Niwa, T.
    Yamaguchi, Y.
    Ishida, T.
    Sasano, H.
    Ohuchi, N.
    Hayashi, I.
    CANCER RESEARCH, 2013, 73
  • [2] The impact of circulating androgens on the androgen receptor in aromatase inhibitor resistant breast cancer
    Creevey, L.
    Ali, A.
    Bleach, R.
    Hill, A. D. K.
    Young, L.
    McIlroy, M.
    CANCER RESEARCH, 2017, 77
  • [3] Potential role of androgen receptor in aromatase inhibitor resistance
    Hunt, Caleb
    Lock, Sarah E.
    Shannon, Cynthia E.
    Varela-Gonzalez, Nichole M.
    Larsen, Randolph K.
    Schech, Amanda J.
    CANCER RESEARCH, 2016, 76
  • [4] Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma
    Fujii, Rika
    Hanamura, Toru
    Suzuki, Takashi
    Gohno, Tatsuyuki
    Shibahara, Yukiko
    Niwa, Toshifumi
    Yamaguchi, Yuri
    Ohnuki, Koji
    Kakugawa, Yoichiro
    Hirakawa, Hisashi
    Ishida, Takanori
    Sasano, Hironobu
    Ohuchi, Noriaki
    Hayashi, Shin-ichi
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 144 : 513 - 522
  • [5] An Investigation of Androgen Receptor Variants in Endocrine Resistant Breast Cancer
    Albanoun, A.
    Mcllroy, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S397 - S397
  • [6] Survival Benefit Conferred by the Androgen Receptor is Lost in Aromatase Inhibitor Treated Breast Cancer
    Ali, A.
    Bane, F.
    Hao, Y.
    McCartan, D.
    O'Gaora, P.
    Hill, A. D. K.
    Young, L.
    McIlroy, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S344 - S345
  • [7] Survival benefit conferred by the androgen receptor is lost in aromatase inhibitor treated breast cancer
    Ali, A.
    Bane, F.
    Hao, Y.
    McCartan, D.
    O'Gaora, P.
    Hill, A. D. K.
    Young, L. S.
    McIlroy, M.
    CANCER RESEARCH, 2013, 73
  • [8] Survival benefit conferred by the androgen receptor is lost in aromatase inhibitor treated breast cancer
    Ali, A.
    Bane, F.
    Hao, Y.
    McCartan, D.
    O'Gaora, P.
    Hill, A. D. K.
    Young, L. S.
    McIlroy, M.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 4 - 4
  • [9] Lasofoxifene as a potential treatment for aromatase inhibitor resistant ER positive breast cancer
    Laine, Muriel
    Greene, Marianne E.
    Leng, Tiffany
    Kurleto, Justyna D.
    Li, Sophia
    Komm, Barry
    Greene, Geoffrey L.
    CANCER RESEARCH, 2022, 82 (04)
  • [10] Androstenedione initiates rapid non-genomic signalling mediated by cytoplasmic androgen receptor in aromatase inhibitor resistant breast cancer
    Bleach, Rachel M.
    Creevey, Laura
    Hill, Arnold D. K.
    Madden, Stephen
    Young, Leonie S.
    Pennington, Stephen R.
    McIlroy, Marie
    CANCER RESEARCH, 2018, 78 (04)
12345